» Articles » PMID: 23370066

Chronobiological Characteristics of Neuropathic Pain: Clinical Predictors of Diurnal Pain Rhythmicity

Overview
Journal Clin J Pain
Specialties Neurology
Psychiatry
Date 2013 Feb 2
PMID 23370066
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Neuropathic pain is often worse at night; however, little is known about pain rhythmicity during waking hours. We aimed to replicate previous observations of diurnal pain progression, evaluate associations between diurnal rhythmicity and clinical factors, and evaluate the impact of diurnal rhythmicity on treatment response.

Methods: We performed exploratory analyses of 2 trials (The New England Journal of Medicine 2005; 352:1324; The Lancet 2009; 374:1252) in diabetic neuropathy and postherpetic neuralgia. Pain recorded at 8:00 AM, 4:00 PM, and 8:00 PM, at baseline and during drug treatment was examined.

Results: Data from the latest trial replicated our previous observation of diurnal pain progression with a relative pain intensity difference of 33% between 8:00 AM and 8:00 PM. This pattern was preserved during treatment with gabapentin, nortriptyline, and their combination. Pooled multivariable analyses suggested that difference in pain intensity from 8:00 AM to 8:00 PM was more pronounced in females (vs. males) and in diabetic peripheral neuropathy (vs. postherpetic neuralgia). The baseline magnitude of pain intensity difference from 8:00 AM to 8:00 PM failed to predict treatment response.

Discussion: These observations suggest that neuropathic pain progressively increases throughout the day with clinically relevant morning-evening differences and further indicate that sex and underlying etiology may be important determinants of diurnal rhythmicity in neuropathic pain. Consideration of these patterns may guide improved therapeutic strategies and stimulate new directions of research that will improve our understanding and treatment of neuropathic pain.

Citing Articles

The contribution of clock genes BMAL1 and PER2 in osteoarthritis-associated pain.

Rodriguez-Palma E, Loya-Lopez S, Allen K, Cruz-Almeida Y, Khanna R Neurobiol Pain. 2025; 17():100177.

PMID: 39850977 PMC: 11754085. DOI: 10.1016/j.ynpai.2024.100177.


Temporal therapy utilizing exosomes derived from M2 macrophages demonstrates enhanced efficacy in alleviating neuropathic pain in diabetic rats.

Wei W, Fang J, Yang B, Cui C, Wei J, Xue Y Korean J Pain. 2024; 38(1):14-28.

PMID: 39711250 PMC: 11695256. DOI: 10.3344/kjp.24244.


Diabetic Neuropathic Pain and Circadian Rhythm: A Future Direction Worthy of Study.

Yang B, Wei W, Fang J, Xue Y, Wei J J Pain Res. 2024; 17:3005-3020.

PMID: 39308994 PMC: 11414757. DOI: 10.2147/JPR.S467249.


Sex-Gender Differences Are Completely Neglected in Treatments for Neuropathic Pain.

Salis F, Sardo S, Finco G, Gessa G, Franconi F, Agabio R Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065689 PMC: 11280170. DOI: 10.3390/ph17070838.


Can the Assessment of the Circadian Rhythm of Pain Be Shortened? A Study of Community-Dwelling Participants with Chronic Pain.

Tanaka Y, Fujii R, Shigetoh H, Sato G, Morioka S J Pain Res. 2024; 17:1929-1940.

PMID: 38812822 PMC: 11135561. DOI: 10.2147/JPR.S452790.